Legal & General Group Plc - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 72 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,594,153
+133.7%
53,603
+41.6%
0.00%
Q2 2023$682,020
+88.3%
37,848
+67.9%
0.00%
Q1 2023$362,104
+24.1%
22,547
+41.4%
0.00%
Q4 2022$291,812
-2.7%
15,946
+4.5%
0.00%
Q3 2022$300,000
+11.5%
15,261
+5.8%
0.00%
Q2 2022$269,000
-14.1%
14,430
+1.3%
0.00%
Q1 2022$313,000
-20.4%
14,241
+2.8%
0.00%
Q4 2021$393,000
+94.6%
13,851
+44.6%
0.00%
Q3 2021$202,000
+110.4%
9,576
+88.0%
0.00%
Q2 2021$96,000
+50.0%
5,093
+20.3%
0.00%
Q1 2021$64,000
+12.3%
4,235
+5.7%
0.00%
Q4 2020$57,000
-9.5%
4,0050.0%0.00%
Q3 2020$63,000
-30.0%
4,005
-21.9%
0.00%
Q2 2020$90,000
+221.4%
5,129
+174.0%
0.00%
Q1 2020$28,000
-48.1%
1,872
-17.2%
0.00%
Q4 2019$54,000
+92.9%
2,262
+22.7%
0.00%
Q3 2019$28,000
-39.1%
1,8430.0%0.00%
Q2 2019$46,000
+39.4%
1,843
+26.0%
0.00%
Q1 2019$33,000
+6.5%
1,463
+38.9%
0.00%
Q4 2018$31,000
+3.3%
1,0530.0%0.00%
Q3 2018$30,0001,0530.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders